BASF-Evonik Merger, BIC Cannabis Pivot, and Pharma Breakthroughs
Analysis of the proposed BASF-Evonik merger, BIC's strategic pivot to the cannabis market, and Novo Nordisk's licensing of Nanexa's PharmaShell technology. Includes insights on fintech consolidation and Berkshire Hathaway's housing bet.